|By Marketwired .||
|May 27, 2014 01:39 PM EDT||
LAS VEGAS, NV -- (Marketwired) -- 05/27/14 -- Earth Science Tech, Inc. (OTCQB: UNOV) ("EST" or "the Company"), a specialty biotechnology company focused on nutraceuticals and bioceuticals, is pleased to announce FINRA has approved of the company's new name "Earth Science Tech, Inc." and new stock symbol "ETST" effective with the start of trading on May 28th, 2014. Earth Science Tech will start trading under the new symbol "ETST" as of May 28th 2014. This new trading symbol "ETST" continues the company's branding and product launch effort in the rapidly expanding nutraceutical and bioceutical markets.
"I am pleased with the continued progress of EST and its branding efforts, including but not limited to the new corporate name change, website and products, and now the successful change of the trading symbol to ETST," stated Harvey Katz, CEO of EST. "We look forward to releasing continued enhancements to our loyal shareholders and the market. Our new ticker "ETST" is a reflection of the significant progress we've made over the past few months and the opportunities that lay ahead."
The company is happy to announce it previously changed its name from "Ultimate Novelty Sports, Inc." to "Earth Science Tech, Inc." upon shareholder approval which was obtained at the Company's Meeting held on February 21, 2014. The company believes the name "Earth Science Tech, Inc." better reflects the nature of its business operations and upcoming growth and expansion in the nutraceutical and bioceutical arena.
ABOUT: EST is a unique biotechnology company focused on cutting edge nutraceuticals and bioceuticals designed to excel in industries such as health, wellness, nutrition, supplement, cosmetic and alternative medicine to improve the quality of life for consumers worldwide. EST is dedicated in providing natural alternatives to prescription medications that help improve common disorders and illnesses. EST is focused on delivering nutritional and dietary supplements that help with treating symptoms such as: chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging and overall wellness. This may include products such as vitamins, minerals, herbs, botanicals, personal care products, homeopathics, functional foods, and other products. These products will be in various formulations and delivery forms including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
FORWARD LOOKING DISCLAIMER: This release contains forward-looking statements that involve risks and uncertainties. Readers are referred to the Securities and Exchange Commission filings filed by the Company on EDGAR at http://www.sec.gov/edgar.shtml, specifically the most recent reports which identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company undertakes no obligation to review or confirm analysts' expectations or estimates or to publicly release any revisions to any forward-looking statements. The information contained in this press release should not be construed as any indication of the Company's future stock price, its revenues or results of operations.